| 标题 |
 Combined exenatide and dapagliflozin has no additive effects on reduction of hepatocellular lipids despite better glycaemic control in patients with type 2 diabetes mellitus treated with metformin: EXENDA, a 24‐week, prospective, randomized, placebo‐controlled pilot trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：Diabetes, obesity and metabolism 作者：J. Harreiter; I. Just; M. Leutner; Magdalena Bastian; H. Brath; et al 出版日期：2021-01-19 |
| 求助人 | |
| 下载 | 求助已完成，仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
秋风
无极微光
DW
Enigma_GEB
极限001
潇洒的惋清
积极凌旋
嘻嘻哈哈
学术文献互助
aaaa
fudandan
平常迎天
YY
学霸业
aa
初景
畔畔
谢雷XIELei
xing_xing
核桃
皖公网安备34019202002308
